The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Arrowhead Pharmaceuticals, ...
November 30 2016 - 04:45PM
Business Wire
Law Offices of Howard G. Smith announces that a class
action lawsuit has been filed on behalf of investors who purchased
Arrowhead Pharmaceuticals, Inc. (“Arrowhead” or the “Company”)
(NASDAQ: ARWR) securities between May 11, 2015 and November 8,
2016, inclusive (the “Class Period”). Arrowhead investors have
until January 16, 2017 to file a lead plaintiff
motion.
Investors suffering losses on their Arrowhead investments are
encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights in this class action at 888-638-4847 or by email
to howardsmith@howardsmithlaw.com.
According to the complaint filed in this lawsuit, Defendants
made materially false and misleading statements and/or failed to
disclose that: (1) ARC-520, one of Arrowhead's drug candidates for
patients with chronic hepatitis B infection, was fatal at certain
doses; (2) consequently, the U.S. Food & Drug Administration
was unlikely to approve ARC-520 as a hepatitis B treatment; (3)
Arrowhead had overstated the approval prospects and commercial
viability of ARC-520; and (4) as a result, Arrowhead's public
statements were materially false and misleading at all relevant
times. When the true details entered the market, the lawsuit claims
that investors suffered damages.
If you purchased shares of Arrowhead during the Class Period you
may move the Court no later than January 16,
2017 to ask the Court to appoint you as lead plaintiff if
you meet certain legal requirements. To be a member of the Class
you need not take any action at this time; you may retain counsel
of your choice or take no action and remain an absent member of the
Class. If you wish to learn more about this action, or if
you have any questions concerning this announcement or your rights
or interests with respect to these matters, please contact Howard
G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol
Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215)
638-4847, toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161130006380/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Feb 2024 to Mar 2024
Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Mar 2023 to Mar 2024